Why Viking Therapeutics may well be ‘onto one thing lovely superb’
Eli Lilly (LLY) and Novo Nordisk (NVO) have change into sizzling shares during the last 12 months because of their blockbuster GLP-1 medicine to regard weight problems.During the last 12 months, Lilly